Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 12:12:1756286419866367.
doi: 10.1177/1756286419866367. eCollection 2019.

Peripheral nerve disease secondary to systemic conditions in children

Affiliations
Review

Peripheral nerve disease secondary to systemic conditions in children

Jo M Wilmshurst et al. Ther Adv Neurol Disord. .

Abstract

This review is an overview of systemic conditions that can be associated with peripheral nervous system dysfunction. Children may present with neuropathic symptoms for which, unless considered, a causative systemic condition may not be recognized. Similarly, some systemic conditions may be complicated by comorbid peripheral neuropathies, surveillance for which is indicated. The systemic conditions addressed in this review are critical illness polyneuropathy, chronic renal failure, endocrine disorders such as insulin-dependent diabetes mellitus and multiple endocrine neoplasia type 2b, vitamin deficiency states, malignancies and reticuloses, sickle cell disease, neurofibromatosis, connective tissue disorders, bowel dysmotility and enteropathy, and sarcoidosis. In some disorders presymptomatic screening should be undertaken, while in others there is no benefit from early detection of neuropathy. In children with idiopathic peripheral neuropathies, systemic disorders such as celiac disease should be actively excluded. While management is predominantly focused on symptomatic care through pain control and rehabilitation, some neuropathies improve with effective control of the underlying etiology and in a small proportion a more targeted approach is possible. In conclusion, peripheral neuropathies can be associated with a diverse range of medical conditions and unless actively considered may not be recognized and inadequately managed.

Keywords: children; peripheral neuropathy; systemic disease.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declare that there is no conflict of interest.

Figures

Figure 1.
Figure 1.
Tumor is seen arising within a plexiform neurofibroma in a patient with of Neurofibromatosis type 1 (NF1) on low-power montage. (Image supplied by Associate Professor Duncan McGregor, Department Head of Anatomical Pathology, The Royal Children’s Hospital, Melbourne, Australia)
Figure 2.
Figure 2.
The same patient with NF-1 as in Figure 1, in this view tumour is seen arising within a plexiform neurofibroma at high magnification illustrating the densely cellular spindle cell sarcoma is visible. (Image supplied by Associate Professor Duncan McGregor, Department Head of Anatomical Pathology, The Royal Children’s Hospital, Melbourne, Australia)

Similar articles

Cited by

References

    1. Shepherd S, Batra A, Lerner DP. Review of critical illness myopathy and neuropathy. Neurohospitalist 2017; 7: 41–48. - PMC - PubMed
    1. Field-Ridley A, Dharmar M, Steinhorn Det al. ICU-Acquired weakness is associated with differences in clinical outcomes in critically ill children. Pediatr Crit Care Med 2016; 17: 53–57. - PMC - PubMed
    1. Vondracek P, Bednarik J. Clinical and electrophysiological findings and long-term outcomes in paediatric patients with critical illness polyneuromyopathy. Eur J Paediatr Neurol 2006; 10: 176–181. - PubMed
    1. Gheith O, Al Otaibi T, Halim Met al. Successful management of critical illness polyneuropathy and myopathy in renal transplant recipients. Exp Clin Transplant 2012; 10: 62–66. - PubMed
    1. Hermans G, De Jonghe B, Bruyninckx Fet al. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev 2009; 1: CD006832. - PubMed